开云app官网登录入口网页版-官方正版

#国家医保目录#

28篇内容 | 1272人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2174746, encodeId=7ce421e474616, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a> <a href='/topic/show?id=ab0e10856901' target=_blank style='color:#2F92EE;'>#进行性纤维化性间质性肺疾病#</a>, objectTitle=治疗进行性纤维化性间质性肺疾病（PPF）的原研药物维加特®纳入国家医保目录，广泛惠及中国肺纤维化患者, objectType=article, longId=804691, objectId=b3bf80469152, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/pexels-photo-3873143.jpeg, objectUrl=/article/show_article.do?id=b3bf80469152, replyNumber=0, likeNumber=95, createdTime=2023-12-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b3bf80469152, moduleTitle=治疗进行性纤维化性间质性肺疾病（PPF）的原研药物维加特®纳入国家医保目录，广泛惠及中国肺纤维化患者, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=b3bf80469152)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2174699, encodeId=cc7e21e469932, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=医保目录重磅更新！降价61.7%126种新药进医保！附2023版医保药品目录, objectType=article, longId=804909, objectId=237d8049098b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230825/1692928230154_2570354.jpg, objectUrl=/article/show_article.do?id=237d8049098b, replyNumber=0, likeNumber=50, createdTime=2023-12-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=237d8049098b, moduleTitle=医保目录重磅更新！降价61.7%126种新药进医保！附2023版医保药品目录, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=237d8049098b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2006212, encodeId=87ed2006212a4, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=哪些药品有望进医保？2022年国家医保目录调整“划重点”, objectType=article, longId=729759, objectId=29a1e2975989, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29a1e2975989, replyNumber=0, likeNumber=113, createdTime=2023-05-27, rootId=0, userName=ms5439512287675881, userId=1d8d2500080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29a1e2975989, moduleTitle=哪些药品有望进医保？2022年国家医保目录调整“划重点”, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=29a1e2975989)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006208, encodeId=aed82006208ea, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=海正药业海博麦布片成功纳入2021国家医保目录，开启国创降脂新时代, objectType=article, longId=211809, objectId=f06b2118095d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f06b2118095d, replyNumber=0, likeNumber=79, createdTime=2021-07-08, rootId=0, userName=ms5439512287675881, userId=1d8d2500080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f06b2118095d, moduleTitle=海正药业海博麦布片成功纳入2021国家医保目录，开启国创降脂新时代, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f06b2118095d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006209, encodeId=ef192006209fa, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=杨森中国又有4个创新药被纳入国家医保目录，6个产品成功续约, objectType=article, longId=217202, objectId=c93d21e20202, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c93d21e20202, replyNumber=0, likeNumber=77, createdTime=2021-12-15, rootId=0, userName=ms5439512287675881, userId=1d8d2500080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c93d21e20202, moduleTitle=杨森中国又有4个创新药被纳入国家医保目录，6个产品成功续约, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c93d21e20202)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006207, encodeId=d651200620e9f, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=刚刚！2021版国家医保目录发布（附全部名单下载）, objectType=article, longId=221485, objectId=a06122148582, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a06122148582, replyNumber=0, likeNumber=55, createdTime=2022-04-04, rootId=0, userName=ms5439512287675881, userId=1d8d2500080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a06122148582, moduleTitle=刚刚！2021版国家医保目录发布（附全部名单下载）, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=a06122148582)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006210, encodeId=43df20062108f, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=君实生物特瑞普利单抗新增两项适应症纳入国家医保目录, objectType=article, longId=221523, objectId=b747221523b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b747221523b7, replyNumber=0, likeNumber=77, createdTime=2022-08-19, rootId=0, userName=ms5439512287675881, userId=1d8d2500080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b747221523b7, moduleTitle=君实生物特瑞普利单抗新增两项适应症纳入国家医保目录, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=b747221523b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006211, encodeId=9d482006211c7, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=淋巴瘤创新药佳罗华®进入2021年国家医保目录, objectType=article, longId=215654, objectId=a5a921565425, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5a921565425, replyNumber=0, likeNumber=68, createdTime=2022-04-21, rootId=0, userName=ms5439512287675881, userId=1d8d2500080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5a921565425, moduleTitle=淋巴瘤创新药佳罗华®进入2021年国家医保目录, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=a5a921565425)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006206, encodeId=5901200620646, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=治疗类风湿关节炎和强直性脊柱炎的生物制剂进入国家医保目录, objectType=article, longId=208008, objectId=22a520800864, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22a520800864, replyNumber=0, likeNumber=0, createdTime=2021-12-24, rootId=0, userName=ms5439512287675881, userId=1d8d2500080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22a520800864, moduleTitle=治疗类风湿关节炎和强直性脊柱炎的生物制剂进入国家医保目录, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=22a520800864)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006205, encodeId=0e052006205df, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=用于治疗慢阻肺的创新产品欧乐欣纳入国家医保目录, objectType=article, longId=184110, objectId=044218411052, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=044218411052, replyNumber=0, likeNumber=69, createdTime=2020-08-12, rootId=0, userName=ms5439512287675881, userId=1d8d2500080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=044218411052, moduleTitle=用于治疗慢阻肺的创新产品欧乐欣纳入国家医保目录, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=044218411052)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006204, encodeId=6f122006204b5, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=礼来与和黄医药共同开发的爱优特®（呋喹替尼胶囊）纳入国家医保目录, objectType=article, longId=183821, objectId=288618382189, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=288618382189, replyNumber=0, likeNumber=65, createdTime=2020-10-01, rootId=0, userName=ms5439512287675881, userId=1d8d2500080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=288618382189, moduleTitle=礼来与和黄医药共同开发的爱优特®（呋喹替尼胶囊）纳入国家医保目录, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=288618382189)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006202, encodeId=5b2c2006202ab, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=全新一代基础胰岛素类似物德谷胰岛素被列入国家医保目录, objectType=article, longId=178023, objectId=3f0c1e80236c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f0c1e80236c, replyNumber=0, likeNumber=85, createdTime=2020-04-16, rootId=0, userName=ms5439512287675881, userId=1d8d2500080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f0c1e80236c, moduleTitle=全新一代基础胰岛素类似物德谷胰岛素被列入国家医保目录, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3f0c1e80236c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006203, encodeId=a917200620305, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=重磅！【茚达特罗/格隆溴铵】进入国家医保目录，以期造福更多慢阻肺患者, objectType=article, longId=183758, objectId=9318183e584b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9318183e584b, replyNumber=0, likeNumber=59, createdTime=2020-02-11, rootId=0, userName=ms5439512287675881, userId=1d8d2500080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9318183e584b, moduleTitle=重磅！【茚达特罗/格隆溴铵】进入国家医保目录，以期造福更多慢阻肺患者, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=9318183e584b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006201, encodeId=ae632006201f3, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=持续大力推进【格隆溴铵单方及茚达特罗/格隆溴铵复方】两药进入国家医保目录，旨在提高药物可及性，造福更多慢阻肺患者, objectType=article, longId=174697, objectId=616a1e46971c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=616a1e46971c, replyNumber=0, likeNumber=52, createdTime=2019-10-19, rootId=0, userName=ms5439512287675881, userId=1d8d2500080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=616a1e46971c, moduleTitle=持续大力推进【格隆溴铵单方及茚达特罗/格隆溴铵复方】两药进入国家医保目录，旨在提高药物可及性，造福更多慢阻肺患者, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=616a1e46971c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006200, encodeId=105d2006200c4, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=国家医保目录调入品种分析, objectType=article, longId=166409, objectId=f20216640917, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f20216640917, replyNumber=0, likeNumber=49, createdTime=2019-07-05, rootId=0, userName=ms5439512287675881, userId=1d8d2500080, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f20216640917, moduleTitle=国家医保目录调入品种分析, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f20216640917)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006198, encodeId=825120061989e, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=新版国家医保目录6月发布，释放3大信号, objectType=article, longId=162406, objectId=d328162406a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d328162406a1, replyNumber=0, likeNumber=116, createdTime=2019-06-16, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d328162406a1, moduleTitle=新版国家医保目录6月发布，释放3大信号, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=d328162406a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006194, encodeId=4d47200619464, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=百济神州宣布维达莎被中国国家医疗保障局纳入国家医保目录, objectType=article, longId=151154, objectId=d1431511547f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1431511547f, replyNumber=0, likeNumber=82, createdTime=2018-11-15, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1431511547f, moduleTitle=百济神州宣布维达莎被中国国家医疗保障局纳入国家医保目录, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=d1431511547f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006199, encodeId=24cf2006199fa, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=国家医保目录，80天后开闸！, objectType=article, longId=162412, objectId=c53b1624128b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c53b1624128b, replyNumber=0, likeNumber=91, createdTime=2019-05-01, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c53b1624128b, moduleTitle=国家医保目录，80天后开闸！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c53b1624128b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006197, encodeId=4040200619eb3, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=国家医保目录，要调整了, objectType=article, longId=160733, objectId=a496160e332f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a496160e332f, replyNumber=0, likeNumber=83, createdTime=2019-10-10, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a496160e332f, moduleTitle=国家医保目录，要调整了, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=a496160e332f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006195, encodeId=d072200619571, content=<a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=这家跨国药企进驻张江24年，5款靶向药被纳入国家医保目录, objectType=article, longId=152653, objectId=52b615265387, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52b615265387, replyNumber=0, likeNumber=73, createdTime=2019-05-31, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52b615265387, moduleTitle=这家跨国药企进驻张江24年，5款靶向药被纳入国家医保目录, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=52b615265387)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

国家医保目录

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#国家医保目录# #进行性纤维化性间质性肺疾病#

治疗进行性纤维化性间质性肺疾病（PPF）的原研药物维加特®纳入国家医保目录，广泛惠及中国肺纤维化患者

2023-12-13发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#国家医保目录#

医保目录重磅更新！降价61.7%126种新药进医保！附2023版医保药品目录

2023-12-13发表于上海

ms5439512287675881 (审核中...)

前往app查看评论内容

#国家医保目录#

哪些药品有望进医保？2022年国家医保目录调整“划重点”

2023-05-27

ms5439512287675881 (审核中...)

前往app查看评论内容

#国家医保目录#

海正药业海博麦布片成功纳入2021国家医保目录，开启国创降脂新时代

2021-07-08

ms5439512287675881 (审核中...)

前往app查看评论内容

#国家医保目录#

杨森中国又有4个创新药被纳入国家医保目录，6个产品成功续约

2021-12-15

ms5439512287675881 (审核中...)

前往app查看评论内容

#国家医保目录#

刚刚！2021版国家医保目录发布（附全部名单下载）

2022-04-04

ms5439512287675881 (审核中...)

前往app查看评论内容

#国家医保目录#

君实生物特瑞普利单抗新增两项适应症纳入国家医保目录

2022-08-19

ms5439512287675881 (审核中...)

前往app查看评论内容

#国家医保目录#

淋巴瘤创新药佳罗华®进入2021年国家医保目录

2022-04-21

ms5439512287675881 (审核中...)

前往app查看评论内容

#国家医保目录#

治疗类风湿关节炎和强直性脊柱炎的生物制剂进入国家医保目录

2021-12-24

ms5439512287675881 (审核中...)

前往app查看评论内容

#国家医保目录#

用于治疗慢阻肺的创新产品欧乐欣纳入国家医保目录

2020-08-12

ms5439512287675881 (审核中...)

前往app查看评论内容

#国家医保目录#

礼来与和黄医药共同开发的爱优特®（呋喹替尼胶囊）纳入国家医保目录

2020-10-01

ms5439512287675881 (审核中...)

前往app查看评论内容

#国家医保目录#

全新一代基础胰岛素类似物德谷胰岛素被列入国家医保目录

2020-04-16

ms5439512287675881 (审核中...)

前往app查看评论内容

#国家医保目录#

重磅！【茚达特罗/格隆溴铵】进入国家医保目录，以期造福更多慢阻肺患者

2020-02-11

ms5439512287675881 (审核中...)

前往app查看评论内容

#国家医保目录#

持续大力推进【格隆溴铵单方及茚达特罗/格隆溴铵复方】两药进入国家医保目录，旨在提高药物可及性，造福更多慢阻肺患者

2019-10-19

ms5439512287675881 (审核中...)

前往app查看评论内容

#国家医保目录#

国家医保目录调入品种分析

2019-07-05

docwu2019 (审核中...)

前往app查看评论内容

#国家医保目录#

新版国家医保目录6月发布，释放3大信号

2019-06-16

docwu2019 (审核中...)

前往app查看评论内容

#国家医保目录#

百济神州宣布维达莎被中国国家医疗保障局纳入国家医保目录

2018-11-15

docwu2019 (审核中...)

前往app查看评论内容

#国家医保目录#

国家医保目录，80天后开闸！

2019-05-01

docwu2019 (审核中...)

前往app查看评论内容

#国家医保目录#

国家医保目录，要调整了

2019-10-10

docwu2019 (审核中...)

前往app查看评论内容

#国家医保目录#

这家跨国药企进驻张江24年，5款靶向药被纳入国家医保目录

2019-05-31

科室
- - 订阅+
  - 更多科室
工具
服务